Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 33.82 | N/A |
| PEG Ratio (TTM) | -21.95 | N/A |
| P/S Ratio (TTM) | 3.99 | N/A |
| P/B Ratio (TTM) | 5.69 | N/A |
| P/FCF Ratio (TTM) | -32.08 | N/A |
| Price to 5YR AVG Earnings Ratio | 51.56 | N/A |
| Price to 5YR AVG FCF Ratio | 156.55 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.17% | N/A |
| ROE (TTM) | 18.00% | N/A |
| Net Profit Margin (TTM) | 11.83% | N/A |
| ROIC 5YR AVG | 15.37% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1.10% | 36.66% | 29.78% |
| Revenue | 2.19% | 11.87% | 12.16% |
| Net Income | -1.00% | 37.68% | 30.69% |
| Cash Flow | 14.28% | 14.49% | 17.86% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.26 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 71.78 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 11.40 | N/A |
| LTL to 5YR AVG FCF | 1.27 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.67% | N/A |